Genetic Regulation of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Plasma Levels and Its Impact on Atherosclerotic Vascular Disease Phenotypes-Reference-Cited by-同舟云学术

Genetic Regulation of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Plasma Levels and Its Impact on Atherosclerotic Vascular Disease Phenotypes

Published:2018-05 Issue:5 Volume:11 Page:
ISSN:2574-8300
Container-title:Circulation: Genomic and Precision Medicine
language:en
Short-container-title:Circ Genom Precis Med.

Author:

Pott Janne¹²,Schlegel Valentin²³,Teren Andrej²⁴,Horn Katrin¹,Kirsten Holger¹²,Bluecher Christina²³,Kratzsch Juergen³,Loeffler Markus¹²,Thiery Joachim²³,Burkhardt Ralph²³,Scholz Markus¹²

Affiliation:

1. Institute for Medical Informatics, Statistics and Epidemiology, Leipzig, Germany (J.P., K.H., H.K., M.L., M.S.)

2. LIFE Research Center for Civilization Diseases, University of Leipzig, Germany (J.P., V.S., A.T., H.K., C.B., M.L., J.T., R.B., M.S.)

3. Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital, Leipzig, Germany (V.S., C.B., J.K., J.T., R.B.)

4. Heart Center Leipzig, Germany (A.T.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference51 articles.

1. New Therapeutic Approaches to the Treatment of Dyslipidemia

2. Biology of proprotein convertase subtilisin kexin 9: beyond low-density lipoprotein cholesterol lowering

3. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

4. Sequence Variations inPCSK9,Low LDL, and Protection against Coronary Heart Disease

5. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing RNA Interference for Cholesterol Lowering: The Bench‐to‐Bedside Story of Inclisiran;Journal of the American Heart Association;2024-03-19

2. Meta-GWAS on PCSK9 concentrations reveals associations of novel loci outside the PCSK9 locus in White populations;Atherosclerosis;2023-12

3. Molecular mechanisms of diabetic heart disease: Insights from transcriptomic technologies;Diabetes and Vascular Disease Research;2023-11

4. Exploring PCSK9 Genetic Impact on Lipoprotein(a) via Dual Approaches: Association and Mendelian Randomization;International Journal of Molecular Sciences;2023-09-28

5. Proteomics and Lipidomics to unveil the contribution of PCSK9 beyond cholesterol lowering: a narrative review;Frontiers in Cardiovascular Medicine;2023-06-12